These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20840873)

  • 21. Choosing the analysis population in non-inferiority studies: per protocol or intent-to-treat.
    Matilde Sanchez M; Chen X
    Stat Med; 2006 Apr; 25(7):1169-81. PubMed ID: 16397861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials.
    Jones AP; Riley RD; Williamson PR; Whitehead A
    Clin Trials; 2009 Feb; 6(1):16-27. PubMed ID: 19254930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modeling missingness for time-to-event data: a case study in osteoporosis.
    Neuenschwander B; Branson M
    J Biopharm Stat; 2004 Nov; 14(4):1005-19. PubMed ID: 15587977
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How can I deal with missing data in my study?
    Bennett DA
    Aust N Z J Public Health; 2001 Oct; 25(5):464-9. PubMed ID: 11688629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An alternative way to classify missing data mechanism in clinical trials--a dialogue on missing data.
    Wei L
    J Biopharm Stat; 2011 Mar; 21(2):355-61. PubMed ID: 21391007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methods for addressing missing data in psychiatric and developmental research.
    Croy CD; Novins DK
    J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1230-40. PubMed ID: 16292114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Missing data mechanisms in a dose-finding adaptive trial.
    Liu K; Entsuah R
    J Biopharm Stat; 2012; 22(2):329-37. PubMed ID: 22251177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Addressing and advancing the problem of missing data.
    Walton MK
    J Biopharm Stat; 2009 Nov; 19(6):945-56. PubMed ID: 20183457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Violation of the intent-to-treat principle and rate of missing data in superiority trials assessing structural outcomes in rheumatic diseases.
    Baron G; Boutron I; Giraudeau B; Ravaud P
    Arthritis Rheum; 2005 Jun; 52(6):1858-65. PubMed ID: 15934058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Etrank: a ranking procedure for handling missing data in clinical trials: application to venlafaxine extended-release depression clinical trial.
    Entsuah R
    J Biopharm Stat; 1996 Nov; 6(4):457-75. PubMed ID: 8969980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outlying observations and missing values: how should they be handled?
    Ludbrook J
    Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):670-8. PubMed ID: 18215187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modelling placebo response in depression trials using a longitudinal model with informative dropout.
    Gomeni R; Lavergne A; Merlo-Pich E
    Eur J Pharm Sci; 2009 Jan; 36(1):4-10. PubMed ID: 19041717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Missing covariate data in medical research: to impute is better than to ignore.
    Janssen KJ; Donders AR; Harrell FE; Vergouwe Y; Chen Q; Grobbee DE; Moons KG
    J Clin Epidemiol; 2010 Jul; 63(7):721-7. PubMed ID: 20338724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Practical usage of O'Brien's OLS and GLS statistics in clinical trials.
    Dallow NS; Leonov SL; Roger JH
    Pharm Stat; 2008; 7(1):53-68. PubMed ID: 17390306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. General statistical design considerations of randomized clinical trials.
    Peduzzi P
    Prog Clin Biol Res; 1988; 264():61-70. PubMed ID: 3289035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analyzing longitudinal data with missing values.
    Enders CK
    Rehabil Psychol; 2011 Nov; 56(4):267-88. PubMed ID: 21967118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analyzing weight loss intervention studies with missing data: which methods should be used?
    Batterham MJ; Tapsell LC; Charlton KE
    Nutrition; 2013; 29(7-8):1024-9. PubMed ID: 23644010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimating treatment effects from longitudinal clinical trial data with missing values: comparative analyses using different methods.
    Houck PR; Mazumdar S; Koru-Sengul T; Tang G; Mulsant BH; Pollock BG; Reynolds CF
    Psychiatry Res; 2004 Dec; 129(2):209-15. PubMed ID: 15590048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dealing with missing values in large-scale studies: microarray data imputation and beyond.
    Aittokallio T
    Brief Bioinform; 2010 Mar; 11(2):253-64. PubMed ID: 19965979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proper analysis in clinical trials: how to report and adjust for missing outcome data.
    Joshi M; Royuela A; Zamora J
    BJOG; 2013 Jul; 120(8):915-9. PubMed ID: 23759083
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.